Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI - Concepedia

Concepedia

Publication | Open Access

Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI

DOI Full Paper Access

26

Citations

25

References

2019

Year

Katrina M. Ingley, Sally M. Burtenshaw, Nicole C. Theobalds, Lawrence M. White, Martin E. Blackstein, Rebecca A. Gladdy, Seng Thipphavong, Abha A. Gupta

Cancer Medicine

Abstract

Low-dose MTX/VNL for a defined duration has high efficacy with sustained benefit and minimal toxicity for treating DF. V<sub>tumor</sub> and T2 signal might better predict treatment response than RECIST.

References

	Year	Citations

Page 1